TWD 27.9
(0.54%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 324.72 Million TWD | 5.61% |
2022 | 307.46 Million TWD | -32.93% |
2021 | 458.41 Million TWD | 27.46% |
2020 | 359.66 Million TWD | 3331.61% |
2019 | 10.48 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 333.86 Million TWD | 0.0% |
2024 Q1 | 333.86 Million TWD | 2.82% |
2023 FY | 324.72 Million TWD | 5.61% |
2023 Q2 | 314.89 Million TWD | 0.0% |
2023 Q1 | 314.89 Million TWD | 2.42% |
2023 Q3 | 324.72 Million TWD | 3.12% |
2023 Q4 | 324.72 Million TWD | 0.0% |
2022 Q3 | 307.46 Million TWD | 0.0% |
2022 Q4 | 307.46 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | 1.61 Billion TWD | 79.933% |
Bioteque Corporation | 1.43 Billion TWD | 77.296% |
Chi Sheng Pharma & Biotech Co., Ltd | 547.04 Million TWD | 40.641% |
Sunder Biomedical Tech. Co., Ltd. | 669.39 Million TWD | 51.491% |
BenQ Medical Technology Corporation | 2.53 Billion TWD | 87.174% |
Pacific Hospital Supply Co., Ltd | 934.33 Million TWD | 65.246% |
Unicon Optical Co., Ltd. | 568.1 Million TWD | 42.841% |
Formosa Optical Technology Co.,Ltd. | 4.17 Billion TWD | 92.221% |
Medeon Biodesign, Inc. | 375.65 Million TWD | 13.558% |
Concord Medical Co., Ltd. | 470.7 Million TWD | 31.014% |
Crystalvue Medical Corporation | 221.36 Million TWD | -46.69% |
ICARES Medicus, Inc. | 239.79 Million TWD | -35.414% |
Lagis Enterprise Co., Ltd. | 304.62 Million TWD | -6.597% |
Amed Co., Ltd. | 459.81 Million TWD | 29.38% |